[1]
“Development and Resolution of Cutaneous Lupus Erythematosus During Long-Term Pexidartinib Therapy”, J of Skin, vol. 10, no. 2, pp. 3022–3026, Mar. 2026, doi: 10.25251/e21k8y47.